Medical Device Regulation in Canada
Health Canada regulates medical devices under the Medical Devices Regulations (SOR/98-282). The four-class risk-based system requires an Establishment Licence for all device companies and a Medical Device Licence (MDL) for Class II–IV. Canada participates in the MDSAP audit program.
Recent Regulatory Updates
Showing the latest 3 updates. Book a demo to see more
IMDRF opens consultation on supplier control guidance
Health Canada mandates REP for Class II-IV devices
Health Canada updates medical device license guidance
Sources Tracked by Qalico
Qalico continuously monitors 12 references across guidelines, regulations, and standards for Canada.
Regulations
Guidelines
Device Classification
Class I (lowest risk, e.g., tongue depressors): Establishment Licence only, no MDL. Class II (low-moderate risk): MDL with declaration of safety/effectiveness. Class III (moderate-high risk): MDL with Technical Summary. Class IV (highest risk, e.g., pacemakers): MDL with full safety and effectiveness data including clinical evidence.
Official classification guidance →Official Guidance Documents
Complete library of Health Canada guidance on classification, licensing, labeling, and post-market requirements.
Guidance on applying for an MDL for Class II, III, and IV devices.
Health Canada's participation in the Medical Device Single Audit Program.
Standards & Key Principles
Applicable Standards
Key Principles
- Risk-based four-class system
- ISO 13485 QMS mandatory for Class II, III, IV manufacturers
- MDSAP audit satisfies Health Canada QMS inspection requirements
- Establishment Licence required for all device manufacturers/importers
- Canadian Authorized Representative required for foreign manufacturers
- Mandatory Problem Reporting within prescribed timelines
Pre-Market Requirements
Required for all manufacturers, importers, and distributors of medical devices. Class I only requires EL, not an MDL.
Declaration of safety and effectiveness with compliance to mandatory standards. Lower evidentiary burden; label review included.
Full Technical Summary (Class III) or comprehensive evidence of safety/effectiveness (Class IV), including clinical data and risk analysis.
Post-Market Requirements
Death or serious injury: report within 10 days. Malfunction likely to cause serious injury: 30 days.
Class II–IV manufacturers must conduct ongoing PMS. Health Canada may request a PMSR at any time.
Health Canada must be notified of all device recalls. Voluntary or mandatory, with timely communication to users.
International Recognition & Reliance
Health Canada accepts FDA marketing authorization data to support MDL applications.
CE marking documentation accepted as supporting evidence for Canadian MDL applications.
MDSAP participant: shared audit reports accepted, reducing regulatory burden.